Nathaniel August‘s Mangrove Partners has reported, in a recent filing with the SEC, that it no longer is an owner of more than 5% of the common stock of Biota Pharmaceuticals Inc (NASDAQ:BOTA). Mangrove Partners now owns only 176 shares of the company.
Recommended reading:
Jim Simons’ Latest Strategy is ‘Out With the New, In With the Old’
Ray Dalio, Bridgewater Make Micron New Top Dog, Love Tech Blue Chips
